Mancia G, Brunstrom M, Burnier M, Grassi G, et al. Rationale of the Inclusion of beta-Blockers Among Major Antihypertensive Drugs in the 2023 European Society of Hypertension Guidelines. Hypertension 2024 Mar 13. doi: 10.1161/HYPERTENSIONAHA.124.22821.
PMID: 38477109